Lonza and Antharis Therapeutics Partner to Develop Next-Generation Dual-Payload ADCs for GI Cancers

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) progra...

June 17, 2026 | Wednesday | News
ZoBio Launches Integrated DNA-Encoded Library Hit Discovery Service to Accelerate Drug Discovery Against Challenging Targets

ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its co...

June 17, 2026 | Wednesday | News
Sanofi’s Tzield Receives FDA Approval as First Disease-Modifying Therapy for Recently Diagnosed Stage 3 Type 1 Diabetes

Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes Accelerat...

June 16, 2026 | Tuesday | News
Volta Labs Launches Automated Twist Fast Hybridization Workflow on Callisto to Accelerate NGS Sample Preparation

Volta Labs, the genomics applications company transforming next-generation sequencing (NGS) sample preparation through automation, announced the launch o...

June 15, 2026 | Monday | News
Roche Secures EU IVDR Approval for Expanded VENTANA MMR RxDx Panel Across Multiple Solid Tumour Indications

Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment ...

June 15, 2026 | Monday | News
Verge Labs and Tenacia Biotechnology Forge Strategic Partnership to Advance CNS Drug Development with Human Tissue Data and AI

First partnership announced under Verge Labs' platform-first model; Tenacia will apply Verge's AI platform and proprietary multimodal...

June 11, 2026 | Thursday | News
Eli Lilly and Company Receives FDA Approval for Every-Eight-Week Maintenance Dosing of EBGLYSS in Atopic Dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the ...

June 11, 2026 | Thursday | News
Aragen Accelerates Daretabart Manufacturing Milestone for Renaissance Pharma Following FDA Fast Track Designation

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the fir...

June 09, 2026 | Tuesday | News
Sapio Sciences and ZS Partner to Accelerate Digital Laboratory Transformation in Biopharma

The partnership combines Sapio Platform capabilities with ZS consulting expertise to deliver integrated laboratory solutions Sapio Sciences, the AI lab i...

June 09, 2026 | Tuesday | News
South Korea Grants Dual Regulatory Designations to Nxera’s Vamorolone for DMD

Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical need without an established treat...

June 05, 2026 | Friday | News
First Foundation Labs and Microsoft Join Forces to Accelerate Life Sciences R&D with Enterprise AI

First Foundation Labs (1FL), a life sciences AI company pioneering clinical and translational reasoning spun out of Luma Group, announced a collaboration...

June 04, 2026 | Thursday | News
Quotient Sciences Initiates First Clinical Study Of An AI Designed Oral Drug Formulation

Phase I study of an AI-designed oral formulation sets a new standard in drug development Quotient Sciences announces the successful initiation of a...

June 01, 2026 | Monday | News
Ginkgo Bioworks Launches ADME-One™ Integrated ADME Platform for AI-Driven Drug Discovery

Ginkgo Bioworks announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery teams co-de...

May 28, 2026 | Thursday | News
Burges Salmon Advises PlaqueTec Limited on Oversubscribed $5 Million Fundraise to Advance BioCarta™ Cardiovascular Data Platform

The Corporate and M&A team from independent UK law firm Burges Salmon has advised PlaqueTec Limited, a Cambridge‑based medtech company pioneering int...

May 28, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close